IRIS
RUSSO, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.197
NA - Nord America 4.933
AS - Asia 4.087
SA - Sud America 1.085
AF - Africa 107
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 16.429
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.782
RU - Federazione Russa 2.976
SG - Singapore 2.196
BR - Brasile 921
CN - Cina 873
IE - Irlanda 751
IT - Italia 714
SE - Svezia 479
HK - Hong Kong 373
DE - Germania 305
PL - Polonia 222
FR - Francia 220
FI - Finlandia 196
VN - Vietnam 182
IN - India 131
GB - Regno Unito 98
UA - Ucraina 78
BD - Bangladesh 61
CA - Canada 60
AR - Argentina 55
MX - Messico 46
TR - Turchia 39
EC - Ecuador 33
JP - Giappone 31
ZA - Sudafrica 31
NL - Olanda 30
ID - Indonesia 29
AT - Austria 25
BE - Belgio 25
IQ - Iraq 23
MA - Marocco 23
CI - Costa d'Avorio 22
UZ - Uzbekistan 20
CO - Colombia 19
PK - Pakistan 19
ES - Italia 17
VE - Venezuela 17
CL - Cile 15
LT - Lituania 13
AZ - Azerbaigian 12
KE - Kenya 11
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
PY - Paraguay 9
SA - Arabia Saudita 9
AU - Australia 8
EU - Europa 8
MY - Malesia 8
PE - Perù 8
PH - Filippine 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
CR - Costa Rica 7
HN - Honduras 7
IL - Israele 7
JM - Giamaica 7
NP - Nepal 7
JO - Giordania 5
OM - Oman 5
PT - Portogallo 5
TH - Thailandia 5
BH - Bahrain 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LB - Libano 4
NI - Nicaragua 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AL - Albania 3
BO - Bolivia 3
EG - Egitto 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
PA - Panama 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
DM - Dominica 2
DZ - Algeria 2
GA - Gabon 2
GT - Guatemala 2
KR - Corea 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
SN - Senegal 2
AM - Armenia 1
BN - Brunei Darussalam 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
ET - Etiopia 1
GY - Guiana 1
KH - Cambogia 1
KY - Cayman, isole 1
Totale 16.418
Salva come PNG Salva come JPEG
Città #
Moscow 923
Ashburn 920
Singapore 801
Dublin 747
Chandler 540
Dallas 513
Hong Kong 373
Beijing 322
Nyköping 321
San Jose 249
Warsaw 220
Messina 206
Jacksonville 186
Munich 157
The Dalles 143
Princeton 128
Ann Arbor 121
Los Angeles 118
Lauterbourg 110
Medford 110
Helsinki 81
Des Moines 79
Cambridge 72
São Paulo 72
Ho Chi Minh City 69
Dearborn 67
New York 64
Council Bluffs 63
Buffalo 57
Tianjin 50
Boardman 48
Bremen 41
Wilmington 38
Redondo Beach 37
Orem 35
Turku 35
Jinan 32
Pune 31
Rio de Janeiro 30
Santa Clara 29
Frankfurt am Main 28
Chennai 27
Tokyo 25
Houston 24
Abidjan 22
Curitiba 22
Hanoi 22
Hyderabad 22
Rome 22
Shenyang 22
Brussels 21
Guangzhou 21
Catania 20
Seattle 20
Tashkent 19
Brasília 18
Brooklyn 18
Chicago 18
Johannesburg 18
Mexico City 18
Nanjing 17
Nuremberg 17
Woodbridge 17
Belo Horizonte 16
Zhengzhou 16
Hebei 15
Jakarta 15
London 15
Milan 15
San Mateo 15
Amsterdam 14
Atlanta 14
Campinas 14
Denver 14
Lappeenranta 14
Montreal 14
Ningbo 14
San Francisco 14
Toronto 14
Palermo 13
Porto Alegre 13
Shenzhen 13
Baku 12
Dong Ket 12
Duncan 12
Guayaquil 12
Lancaster 12
Shanghai 12
Taizhou 12
Changsha 11
Vienna 11
Baghdad 10
Hangzhou 10
Istanbul 10
Poplar 10
Quito 10
Redwood City 10
Ribeirão Preto 10
Salvador 10
Boston 9
Totale 9.183
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 366
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 330
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 285
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 258
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 250
Clinical and pathological features of focal myositis 248
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 248
Etanercept for psoriasis and psoriatic arthritis in a patient with Charcot-Marie-Tooth disease 245
A Nouvel serum MicroRNA signature to screen ATTR 229
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 216
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 212
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 199
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 198
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 193
Alexithymia, burden and resilience in ALS’ caregivers 193
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 189
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy 182
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 177
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 175
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 174
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 172
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 171
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 170
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 168
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 167
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 166
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 166
Autoimmune juvenile limb-girdle myasthenia 165
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 161
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 160
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 159
Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study 159
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis 158
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 158
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study 156
Emotional burden and coping strategies in amyotrophic lateral sclerosis caregivers: The role of metacognitions 156
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 156
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 155
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 154
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 152
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 148
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 148
The 6-min walk test as a new outcome measure in Amyotrophic lateral sclerosis 148
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 144
Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis 144
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 142
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 142
La deformazione longitudinale e radiale del ventricolo sinistro è ridotta nell’amiloidosi cardiaca familiare: studio con ecocardiogramma bi-dimensionale e risonanza magnetica cardiaca. 139
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 137
AUTONOMIC DYSFUNCTION AND HEART INVOLVEMENT IN TRANSTHYRETIN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY 135
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 133
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 130
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 129
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 129
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS). 128
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy 127
Considerable post-partum worsening in a patient with CMT2E 126
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 126
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 125
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 123
The Role of NLRP3 Inflammasome in the Pathogenesis of Traumatic Brain Injury 120
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 119
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 114
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 114
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 113
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 113
Miopatia prossimale in paziente con sindrome di Williams 109
Factors predicting survival in ALS: a multicenter Italian study 106
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 106
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 106
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 105
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 104
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 103
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 102
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 102
Corneal Sub-Basal Nerve Plexus in Non-Diabetic Small Fiber Polyneuropathies and the Diagnostic Role of In Vivo Corneal Confocal Microscopy 99
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 99
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 96
Repurposing chemotherapy-induced peripheral neuropathy grading 95
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 95
The THAOS: record of patients from our site. 95
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 92
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 91
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 90
Variable phenotypes are associated with PM22 missense mutations. 90
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 89
Left atrial function in cardiac amyloidosis 88
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 87
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 87
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 87
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 86
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: Secondary analysis of data from the CI-PeriNomS study 86
Nuclear factor-kappaB, mitogen-activated protein kinases and cyclooxygenase/5-lipoxygenase pathway inhibition by flavocoxid improves muscle function and morphology in mdx mice: a comparison study with methylprednisolone. 85
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers 85
Correlation between morphologic and functional echocardiographic indexes and semiquantitative analysis of 99mTC-DPD scintigraphy in patients with transthyretin related amyloidosis 84
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 84
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 84
Prominent distal lower limbs involvement with hyperreflexia in a family with seipin related axonal motorneuropathy. 83
TRANSTHYRETIN AMYLOIDOSIS IN SOUTHERN ITALY POPULATION: DESCRIPTION OF A COHORT OF PATIENTS WITH PHE64LEU MUTATION AND LATE ONSET 82
Systematic investigation on needs and use of technological device in amyotrophic lateral sclerosis patients and caregivers: a natinwide, multicentre survey. 81
Totale 14.355
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202129 0 0 0 0 0 0 0 0 0 0 0 29
2021/2022759 19 89 5 30 49 11 74 41 26 50 59 306
2022/20232.033 165 185 110 149 158 169 20 94 912 7 43 21
2023/2024517 42 77 26 38 53 121 20 32 7 35 15 51
2024/20253.588 46 52 64 177 146 128 186 551 643 170 655 770
2025/20267.895 402 605 585 539 695 1.548 987 954 894 394 150 142
Totale 16.827